Codiak Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a…
Month: February 2021
Revive Therapeutics Receives Receipt for Final Short-Form Prospectus for Previously Announced $20 Million Bought Deal Public Offering
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Feb….
Zealand Pharma to participate in SVB Leerink 9th Annual Global Healthcare Conference
Press Release – No. 7 / 2021 Copenhagen, DK and Boston, MA, February 9, 2021 – Zealand…
Immunocore Announces Closing of $312.1 Million Aggregate Financing, Consisting of $297.1 Million Initial Public Offering, Full Exercise of Option to Purchase Additional ADSs and $15.0 Million Concurrent Private Placement
PRESS RELEASE Immunocore Announces Closing of $312.1 Million Aggregate Financing, Consisting of $297.1 Million Initial…
Angion Biomedica Corp. Announces Closing of $117 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
UNIONDALE, N.Y., Feb. 09, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp. (Angion) (NASDAQ:ANGN), a late-stage…
Tonix Pharmaceuticals Holdings Corp. Closes $70M Common Stock Offering Priced At-The-Market Under Nasdaq Rules
CHATHAM, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) — TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or…
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Business Update
U.S. FDA reviewing premarket approval (PMA) submission for LungFitTM PH to treat persistent pulmonary hypertension…
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February and March
CANTON, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Bolt Biotherapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
REDWOOD CITY, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) — Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a…
Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares
CAMBRIDGE, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) — Vor Biopharma (Nasdaq: VOR), a cell therapy…
Codexis Announces Expansion to New Facility to Accommodate Next Stage of Growth
REDWOOD CITY, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
Assertio Holdings, Inc. Announces Closing of Registered Direct Offering of $14 Million
LAKE FOREST, Ill., Feb. 09, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
LONDON and REDWOOD CITY, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc…
Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
MENLO PARK, Calif. and BOSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (“Adicet”)…
Pharvaris Announces Closing of Initial Public Offering
ZUG, Switzerland, Feb. 09, 2021 (GLOBE NEWSWIRE) — Pharvaris N.V. (“Pharvaris”) (Nasdaq: PHVS), a clinical-stage…
Agenus Announces Agenus Insights – Virtual R&D Miniseries
Season 1 Episode 1 (S1E1) on “Optimally Targeting TIGIT” LEXINGTON, Mass., Feb. 09, 2021 (GLOBE…
Infant Bacterial Therapeutics today announces that new patent protection is granted in Japan
Infant Bacterial Therapeutics AB today announces that the Japan Patent Office has issued a decision…
The Capital Group holds 10.03% of Galapagos shares
Mechelen, Belgium; 9 February 2021; 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ:…
Verizon 5G Ultra Wideband leveraged by Zyter for in-stadium tech
BASKING RIDGE, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) — Verizon Business announced today they are…
Intrado Announces Launch of Emergency Data Broker
New solution spans Company’s continuum of life and safety products, bridging information delivery between the…